.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
India faces uniquely high stakes in the fight against drug-resistant infections. Specifically, C-CAMP recently hosted the second India AMR Innovation workshop in Delhi to address these challenges. Therefore, the event gathered over one hundred stakeholders to discuss collaborative strategies. Furthermore, the workshop highlighted breakthrough innovations supported by the India AMR Innovation Hub (IAIH). Consequently, the Principal Scientific Adviser launched a compendium of sixty AMR solutions. This collection features tools for diagnostics, therapeutics, and environmental monitoring. While these solutions are diverse, they all follow the One Health approach. Moreover, the IAIH now serves as the official innovation arm of India's National Action Plan (NAP) 2.0.
In addition, C-CAMP introduced the first-of-its-kind IAIH Grand Challenges. These challenges aim to incentivize solutions for critical and underfunded problems. For instance, bioremediation of antibiotic waste remains a key priority. Similarly, affordable rapid diagnostics for primary health centers require urgent attention. Consequently, the new IAIH Impact Fund will provide unified funding for biotech startups. Specifically, it supports companies from the TRL-4 stage onwards. This funding aims to improve both commercial success and public health impact. Furthermore, the workshop unveiled a new cohort of seven startups. These companies focus on detecting resistant microbes in environmental samples.
Q1: What is the primary goal of the India AMR Innovation Hub (IAIH)?
The hub aims to build a pipeline of 10–15 fully mature solutions over the next five years. These solutions will target deployment in India and other low- and middle-income countries to reduce the burden of resistance.
Q2: How does the National Action Plan (NAP) 2.0 support AMR innovation?
NAP 2.0 provides a strategic framework that integrates human, animal, and environmental health. It leverages platforms like IAIH to bridge the gap between scientific discovery and large-scale clinical implementation.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
C-CAMP hosts the 2nd India AMR Innovation Workshop, launching Grand Challenges and an Impact Fund to support startups fighting antimicrobial resistance....
5 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
